Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

NCT05588128 · clinicaltrials.gov ↗

RECRUITING

Status

350

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer
Biochemically Recurrent

Interventions

DRUG: 18F-DCFpyL

Sponsor

National Cancer Institute (NCI)